NW-G01 is a novel cyclic hexapeptide antibiotic produced by Streptomyces alboflavus 313. Its relative structure was established by HR-ESI-MS, IR, 1D and 2D NMR techniques, the absolute structure was determined using a combination of single-crystal X-ray diffraction and Marfey's method finally. The antibiotic consists of L-valine, (3S)-and (3R)-piperazic acids, N-methyl-Dalanine and (2S,3aR,8aS)-6-chloro-3a-hydroxy-1, 2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid.
INTRODUCTION
In the course of a screening program for new antibiotics, NW-G01, a novel cyclic hexapeptide antibiotic, was isolated from the fermentation broth of Streptomyces alboflavus 313. The chemical structure of NW-G01 is composed of a molecule of valine, N-methylalanine, a chlorinated pyrroloindoline derivative, and three molecules of piperazic acids ( Figure 1 ). NW-G01 is structurally related to himastatin 1 and chloptosin, 2 two cyclic hexapeptide antitumor antibiotics, but is significantly different in the amino-acid content. Another important difference from them is that the two reported antibiotics are the dimers of hexapeptide. The bioassay results showed that NW-G01 had strong antibacterial activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, but was ineffective against gram-negative bacteria.
The taxonomy of the producing strain, fermentation, isolation, physicochemical properties and antibacterial activities of the antibiotic have been previously reported. 3 In this paper, the structure elucidation of NW-G01 will be described.
RESULTS

Physicochemical properties
The molecular formula of NW-G01 was determined to be C 35 H 49 N 10 O 7 Cl (m/z, found 757.3640[M+H] + , calcd 757.3552) on the basis of HR-ESI-MS measurement, and the presence of chlorine was suggested by the isotope abundance peaks in the MS spectrum. The IR spectrum of NW-G01 exhibited absorption bands at 3425, 1638, 1114 and 1073 cm À1 , indicating peptidic moieties in the molecule, and UV (MeOH) absorptions at l max 218 nm and l max 346 nm indicated the presence of aromatic ring(s).
Structure elucidation
The 13 C and 1 H NMR data of NW-G01 are summarized in Table 1 . The 1 H and 13 C NMR spectra of NW-G01 showed typical signals for a cyclopeptide. There were six amide carbonyl carbons (d 175.4, 174.6, 172.6, 172.2, 170.2 and 170.0) in the 13 C NMR spectrum. The 13 C NMR (DEPT) spectrum showed 35 carbon signals, which were attributed to four methyl carbons, ten methylene carbons, eight methine carbons, three aromatic methine carbon, one oxygenated quaternary carbon, two quaternary carbons, one chloridated quaternary carbon, six carbonyl carbons by analysis of DEPT and heteronuclear single quantum coherence spectra. Combining the key information with 2D NMR data and the relative references, 2,4,5 a piperazic acid moiety was considered. In the same manner, it was confirmed that another two molecules of piperazic acid moiety were in the hexapeptide antibiotic.
The sequence of the amino-acid residues in NW-G01 was established by the analysis of HMBC data, which showed correlation from the a-methine protons of amino-acid residue to carbonyl carbon of the neighboring residues (Figure 2) .
Stereochemistry of NW-G01
Finally, the crystals ( Figure 3 ) suitable for X-ray crystallographic analysis were obtained fortunately. The results obtained from this analysis defined the relative chemistry at all centers. The relative configurations of the PA-1, PA-3, MeAla and Trp derivatives were S* and those of the valine and PA-2 derivatives were R*. As these standard amino acids were not directly obtained except for D-and L-valine, the absolute configurations of the amino-acid residues were deduced from the direction of this known absolute configuration of valine.
The absolute configuration of the valine residues was determined by application of the Marfey's method using 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide (FDAA) [6] [7] [8] and subsequent HPLC analysis of the acid hydrolysate of NW-G01. Marfey's analysis revealed the presence of L-valine in the acid hydrolysate of NW-G01, and the absolute configuration of MeAla was deduced as D-configuration based on X-ray crystal diffraction analysis. Thus, the absolute stereochemistry of amino acid groups composed of NW-G01 was determined and confirmed as L-valine, (2S,3aR,8aS)-6-chloro-3a-hydroxy-1,2,3,3a,8, 8a-hexahydropyrrolo [2,3-b] indole-2-carboxylic acid, (3S)-piperazic acid (PA-1), N-methyl-D-alanine, (3R)-piperazic acid (PA-2) and (3S)-piperazic acid (PA-3).
DISCUSSION
The complete structure of NW-G01 was determined using spectral analysis and single-crystal X-ray diffraction. It is structurally characterized as an 18-membered cyclic hexapeptide composed of two amino-acid residues including an L-amino acid and nitrogen-bearing heterocyclic rings, including a chlorine atom on the pyrroloindoline moiety. The structure of NW-G01 is closely related to chloptosin, produced by Streptomyces MK498-98F14 stain, such as, the presence of the uniform chlorine atom on the pyrroloindoline moieties, 6-chloro3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b] indole-2-carboxylic acid. 2 However, it is significantly different in the amino-acid content, especially, the former was a monomer and contained L-valine and N-methyl-D-alanine residues, but the latter was a dimer and included O-methyl-D-serine, D-valine and D-threonine groups.
From our previous study, it was found that NW-G01 had higher antibacterial activities than ampicillin against four tested gram-positive NW-G01: a novel cyclic hexapeptide antibiotic Z Guo et al bacteria, especially to methicillin-resistant Staphylococcus aureus (MIC 7.81 mg ml À1 ), 3 and had strong activities against human hepatoma cell line BEL-7402 and human colon cancer cell line HCT-116 cultured in vitro. Further pharmacological studies and an investigation of the mechanism of action are now underway.
EXPERIMENTAL SECTION General
HR-ESI-MS was measured on a Bruker APX500 analytical spectrometer (Bruker, Shanghai, China). 1 H-and 13 C-NMR spectra and 2D NMR were obtained in CDCl 3 on a Bruker AV-500 spectrometer, using CDCl 3 as solvent and TMS as an internal standard. IR spectra were recorded on a Bruker VECOR22 FT-IR spectrometer using KBr pellets. All solvents and chemicals were of analytical grade.
Marfey's analysis
Approximately 1.0 mg of NW-G01 was hydrolyzed with 100 ml of 6N HCl at 110 1C for 24 h. The acid hydrolysate was evaporated to dryness and dissolved in 100 ml of 0.1N HCl. To 50 ml of the acidic solution, 80 ml of 1 N NaHCO 3 and 400 mg FDAA (Marfey's reagent, J&K Chemical, Beijing, China) with 40 ml acetone was added, and the mixture was heated at 50 1C for 1 h. The reaction mixture was cooled to room temperature, neutralized with 40 ml 1N HCl, and evaporated to dryness 
X-ray crystallographic data of NW-G01
A needle-shaped crystal was obtained by slow evaporation of a methanol solution of the compound. Single-crystal X-ray diffraction measurements were made on a Bruker SMART 1000 CCD diffractometer with graphite-monochromated Mo Ka radiation (l¼0.71073 Å ) at 295(2) K. NW-G01: a novel cyclic hexapeptide antibiotic Z Guo et al
